MARÍA JOSÉ
PARELLADA REDONDO
Profesora titular de universidad
Centro de Investigacion Biomedica en Red de Salud Mental
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Salud Mental (102)
2024
-
Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders
Biological Psychiatry, Vol. 96, Núm. 5, pp. 376-389
-
Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation
Schizophrenia Bulletin, Vol. 50, Núm. 2, pp. 327-338
-
Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis
Psychological Medicine, Vol. 54, Núm. 7, pp. 1339-1349
-
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk
Psychiatry Research, Vol. 332
-
Health service and psychotropic medication use for mental health conditions among healthcare workers active during the Spain Covid-19 Pandemic – A prospective cohort study using web-based surveys.
Psychiatry Research, Vol. 334
-
Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN
Schizophrenia, Vol. 10, Núm. 1
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
-
Novel risk loci for COVID-19 hospitalization among admixed American populations
eLife, Vol. 13
-
Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations
Schizophrenia Research, Vol. 267, pp. 534-545
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Analysis of common genetic variation across targets of microRNAs dysregulated both in ASD and epilepsy reveals negative correlation
Frontiers in Genetics, Vol. 14
-
Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up
International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807
-
Autism care pathway in Europe
European Psychiatry, Vol. 66, Núm. 1
-
Autism with co-occurring epilepsy care pathway in Europe
European Psychiatry, Vol. 66, Núm. 1
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280
-
Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
Psychiatry Research, Vol. 323
-
Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients
Revista de Psiquiatria y Salud Mental
-
Oxytocin Exposure in Labor and its Relationship with Cognitive Impairment and the Genetic Architecture of Autism
Journal of Autism and Developmental Disorders, Vol. 53, Núm. 1, pp. 66-79
-
Recent natural selection conferred protection against schizophrenia by non-antagonistic pleiotropy
Scientific Reports, Vol. 13, Núm. 1
-
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study
European Neuropsychopharmacology, Vol. 67, pp. 53-65